Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 17.02.2026 FVD. IE00BKVKW020 250,002.00 USD 7,511,951.46 30.048  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 17.02.2026 UIGB IE00079WNSI6 8,816.00 GBP 230,175.32 26.109  ...

BOSTON--(BUSINESS WIRE)--MEFA today announced that its prepaid tuition program, the U.Plan, will transition to a new platform powered by Catalis, an integrated payments and SaaS partner with deep experience supporting the postsecondary education savings industry. This transition coincides with an important milestone for the program, as the U.Plan, established in 1995, recently celebrated its 30th year serving Massachusetts families. Beginning February 17th, the updated U.Plan platform will offe...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 17.02.2026 FCSG IE00BKPSPT20 1,400,002.00 USD 62,230,534.60 44.450  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 17.02.2026 UNCU.LN IE00BD6GCF16 816,921.00 USD 37,076,722.18 45.386  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 17.02.2026 FXGB LN IE00BD5HBR05 37,992.00 GBP 756,458.36 26.887  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 17.02.2026 UINC IE00BZBW4Z27 9,869,448.00 USD 376,182,413.78 38.116  ...

WALTHAM, Mass.--(BUSINESS WIRE)--Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating cardiovascular diseases, today announced that the European Medicines Agency (EMA) has granted Orphan Drug designation to Affinia for AFTX-201. AFTX-201 is a potential first-in-class and best-in-class investigational genetic medicine for the treatment of BAG3-associated di...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 17.02.2026 FTFX IE00BD5HBQ97 63,402.00 USD 1,671,297.59 26.360  ...

CAESAREA, Israel--(BUSINESS WIRE)--Delta Galil Industries, Ltd. today reported financial results for the fourth quarter and year ended December 31, 2025....